Evidence map›Paper›PMID 34216722›Full record

ArticleToxicology in vitro : an international journal published in association with BIBRA2021

Modeling the antioxidant properties of the eye reduces the false-positive rate of a nonanimal eye irritation test (OptiSafe).

Stewart J Lebrun, Sara Chavez, Roxanne Chan, Linda Nguyen, James V Jester

Abstract read
In one paragraph

Article in Toxicology in vitro : an international journal published in association with BIBRA, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Washing with buffered vitamin C after corrosive chemical (sodium hypochlorite) exposure reduces ocular depth of injury.Toxicology in vitro : an international journal published in association with BIBRA · 2025
    Article
  2. Article
  3. Evaluation of a New In Chemico Skin Corrosion Test.Toxicology in vitro : an international journal published in association with BIBRA · 2024
    Article
  4. Article
  5. Expansion of the application domain of a macromolecular ocular irritation test (OptiSafe™).Toxicology in vitro : an international journal published in association with BIBRA · 2023
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Stewart J LebrunLebrun Labs LLC, Anaheim, CA, United States of America. Electronic address: SJ@lebrunlabs.com.
Sara ChavezLebrun Labs LLC, Anaheim, CA, United States of America.
Roxanne ChanLebrun Labs LLC, Anaheim, CA, United States of America.
Linda NguyenLebrun Labs LLC, Anaheim, CA, United States of America.
James V JesterDepartment of Ophthalmology and Biomedical Engineering, University of California Irvine, Irvine, CA, United States of America.

Funding

Non-Animal Test Method to Determine the Ocular Safety of Consumer Products and Chemicals: Phase IIR44ES025501 · NIEHS · LEBRUN LABS, LLC · PI LEBRUN, STEWART · 2019 to 2020
$1.5M
NIEHS NIH HHS R44 ES025501
6 · The paper itself

Abstract

We recently identified a group of chemicals that are misclassified by most, if not all, in vitro alternative ocular irritation tests, suggesting that nonanimal tests may not fully model the ocular environment in which these chemicals interact. To address this, we evaluated the composition of tears, the first defense against foreign substances, and identified the presence of antioxidants that could detoxify reactive chemicals that otherwise may be falsely identified as irritants in alternative irritation tests. In this study, we evaluated the effects of tear antioxidants on the ocular irritation scoring of commonly overclassified chemicals (false positives) using the OptiSafe™ ocular irritation test. Six tear-related antioxidants were individually added to the OptiSafe formulation, and the effects on test outcome were determined. Ascorbic acid, the most abundant water-soluble antioxidant in tears, specifically reduced the OptiSafe false-positive rate. Titration curves showed that this reduction occurs at in vivo concentrations and is specific to chemicals identified either as producing reactive oxygen species or as crosslinkers. Importantly, the addition of tear antioxidants did not impact the detection of true negatives, true positives, or other false positives unassociated with reactive oxygen species or crosslinking. These results suggest that the addition of tear antioxidants to in vitro alternative test systems may substantially reduce the false-positive rate and improve ocular irritant detection.

Indexed as

Animal Testing AlternativesAntioxidantsAscorbic AcidEyeIrritantsModels, BiologicalOxidation-ReductionTearsToxicity TestsAntioxidantsAscorbic AcidIrritantsAntioxidantsEye irritationFalse positiveTear

Identifiers

PMID34216722
PMCPMC8522283

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.